Previous 10 | Next 10 |
Sorrento (SRNE) was Friday's headline trade. The company's CEO stunned the world by claiming that Sorrento had a 100% efficient cure for COVID-19. Investors and speculators alike flocked to the company's stock and sent the price to the moon. This is one of those cases where you have to act fas...
Many drugmakers are rushing to develop potential therapies and vaccines for novel coronavirus disease COVID-19. But two of them have been in the spotlight in recent days. Moderna (NASDAQ: MRNA) announced positive interim data on Monday from an early-stage clinical study of its COVID-1...
After jumping as much as 282% from Thursday's closing price to the high yesterday, Sorrento Therapeutics (NASDAQ: SRNE) dropped 16.6% on Tuesday on no apparent news -- other than, of course, that the biotech had jumped a 282% in less than two trading days, followed by a dose of reality as it...
Gainers: Nano Dimension NNDM +272% . More news on: ShiftPixy, Inc., Mercurity Fintech Holding Inc., Iterum Therapeutics plc, Stocks on the move, , Read more ...
May 19, 2020 Palm Beach, FL – May 19, 2020 – The global science community is arguably facing one of its greatest challenges yet in the current global healthcare crisis. Article after article demonstrates that the global pandemic is causing the breakdown of soci...
You know a company has some really good news when its stock skyrockets 144% in a single day . That's exactly what Sorrento Therapeutics (NASDAQ: SRNE) shares did on Friday. And it looked like the biotech's momentum would keep going on Monday, with Sorrento soaring more than 40% early b...
( Pexels ) Next to technology, healthcare has been the top-performing sector so far this year. Equities in the sector saw moderate declines during the March crash as investors discount higher revenue for many firms. Since the market's March lows, the Health Care Select Sect SPDR ETF's ( XLV ...
Sorrento Therapeutics (NASDAQ: SRNE) , a clinical-stage biotech, is off to a strong start this week. The drugmaker's shares are up by a healthy 42.6% in pre-market trading Monday morning. Last Friday, Sorrento's shares gained an astounding 158% in response to the company's announceme...
Sorrento Therapeutics (NASDAQ: SRNE ) +36% in reaction to reports that it has discovered an antibody, dubbed STI-1499, that, it says, can provide 100% inhibition of COVID-19. More news on: Sorrento Therapeutics, Inc., Moderna, Inc., Fulgent Genetics, Inc., Stocks on the ...
Vital Knowledge Media joined Stat's Adam Feuerstein in voicing skepticism over Friday's announcement that Sorrento Therapeutics (NASDAQ: SRNE ) had discovered an antibody, dubbed STI-1499, that, it says, can provide 100% inhibition of COVID-19. More news on: Sorrento Therapeutics, Inc....
News, Short Squeeze, Breakout and More Instantly...
Sorrento Therapeutics Inc. Company Name:
SRNE Stock Symbol:
NASDAQ Market:
Sorrento Therapeutics Inc. Website:
What goes up usually comes down, and that's exactly what happened with Sorrento Therapeutics (NASDAQ: SRNE) today. Shares of Sorrento were crashing 30.4% as of 3:38 p.m. ET on Wednesday after soaring more than 60% on Tuesday. Sorrento's huge surge yesterday came after the company anno...
A California-based %Biotech company is turning heads Wednesday morning after it was announced that the U.S. Bankruptcy Court granted an interim approval of the company’s $75 million debtor-in-possession financing. While bankruptcy court can get a little messy, traders seem to b...